Stay updated on TV-1106 in GH-Deficient Adults Clinical Trial
Sign up to get notified when there's something new on the TV-1106 in GH-Deficient Adults Clinical Trial page.

Latest updates to the TV-1106 in GH-Deficient Adults Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added; a funding/operating status notice and Revision: v3.4.1 were removed, and these site-wide updates do not modify the study record, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoChange DetectedA government funding lapse notice has been added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedNew UI element 'Show glossary' is added, and the 'Last Update Submitted that Met QC Criteria' label appears in the Study Record Dates section. The page footer now shows 'Revision: v3.4.0' and capitalization of 'No FEAR Act Data' has been updated.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page footer revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now includes a consolidated Locations section with state-level site entries (California, Florida, Illinois, Indiana, Michigan, Nevada, New York, North Carolina, Pennsylvania, Texas) and references a new revision (v3.3.3). The older state-specific location listings and the HHS Vulnerability Disclosure link were removed.SummaryDifference1.0%

- Check92 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page. This appears to be a routine site version update with no changes to the study details, criteria, or results.SummaryDifference0.0%

Stay in the know with updates to TV-1106 in GH-Deficient Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TV-1106 in GH-Deficient Adults Clinical Trial page.